Back to Search
Start Over
Origin of Residual Tumor Masses in BRCA1/2-Driven Ovarian Carcinomas Treated by Neoadjuvant Chemotherapy: Selection of Preexisting BRCA1/2-Proficient Tumor Cells but Not the Gain of Second ORF-Restoring Mutation.
- Source :
- Pathobiology; 2024, Vol. 91 Issue 2, p108-113, 6p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 10152008
- Volume :
- 91
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Pathobiology
- Publication Type :
- Academic Journal
- Accession number :
- 176448665
- Full Text :
- https://doi.org/10.1159/000533591